Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 6.99
(-1.55%)
CNY 6.99
(-1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 58.46 Million | 127.81 Million | 108.72 Million | 176 Million | 156.8 Million | 175.75 Million |
| Net Income | -83.2 Million | -4.62 Million | 108.91 Million | 153.99 Million | 342.43 Million | 147.76 Million |
| Depreciation & Amortization | 84.46 Million | 77.64 Million | 62.8 Million | 42.7 Million | 20.62 Million | 17.55 Million |
| Deferred income taxes | -18.01 Million | -8.52 Million | -5.99 Million | -2.66 Million | 29.71 Million | 10.43 Million |
| Stock-based compensation | - | 1.01 Million | 506.9 Thousand | 7.37 Million | 2.47 Million | - |
| Change in working capital | -55.78 Million | 8.45 Million | -40.15 Million | -6.11 Million | -2 Million | 23.68 Million |
| Other non-cash items | 112.98 Million | 46.32 Million | -22.83 Million | -14.58 Million | -204.24 Million | -13.25 Million |
| Investing Cash Flow | -114.31 Million | -97.76 Million | -144.04 Million | -151.2 Million | -77.05 Million | -198.11 Million |
| Investments in PPE | -144.6 Million | -102.78 Million | -147.75 Million | -172.1 Million | -34.98 Million | -54.05 Million |
| Acquisitions | 21.96 Million | -123.29 Million | 170.51 Thousand | 6.39 Million | 35.13 Million | 54.13 Million |
| Investment purchases | -736.3 Million | -1.17 Billion | -25 Million | -70 Million | -48.01 Million | -147.02 Million |
| Sales/Maturities of investments | 8.32 Million | 13.72 Million | 12.68 Million | 9.29 Million | 5.79 Million | 2.88 Million |
| Other Investing Activities | 21.96 Million | 1.29 Billion | 15.85 Million | 75.19 Million | -34.98 Million | -54.05 Million |
| Financing Cash Flow | 53.17 Million | -153.73 Million | -99.95 Million | 722.59 Million | -22.39 Million | -12.06 Million |
| Debt repayment | -107.75 Million | -79 Million | -219.41 Million | -105.5 Million | - | - |
| Dividends payments | -34.43 Million | -34.33 Million | -29.42 Million | -34.61 Million | -48.89 Million | -12.06 Million |
| Common Stock Repurchased | -99.68 Thousand | -3.39 Million | -8.37 Million | -904.41 Thousand | - | - |
| Common Stock Issuance | - | 3.39 Million | 8.37 Million | 904.41 Thousand | - | - |
| Other Financing Activities | -3.86 Million | -28.74 Million | 164.35 Million | 869.61 Million | 26.5 Million | - |
| Accounts receivables | -52.9 Million | 33.88 Million | 60.4 Million | -13.75 Million | -23.99 Million | -22.37 Million |
| Accounts payables | -9.57 Million | 10.13 Million | 36.47 Million | -3.06 Million | 20.23 Million | 20.49 Million |
| Inventory | 24.7 Million | -27.02 Million | -131.04 Million | 13.36 Million | -27.96 Million | 15.12 Million |
| Other working capital | -80.49 Million | -8.52 Million | -5.99 Million | -2.66 Million | 29.71 Million | 8.55 Million |
| Cash at beginning of period | 736.94 Million | 860.33 Million | 995.79 Million | 248.4 Million | 191.04 Million | 225.46 Million |
| Cash at end of period | 731.73 Million | 736.94 Million | 860.33 Million | 995.79 Million | 248.4 Million | 191.04 Million |
| Capital Expenditure | -144.6 Million | -102.78 Million | -147.75 Million | -172.1 Million | -34.98 Million | -54.05 Million |
| Effect of forex changes on cash | -2.52 Million | 294.69 Thousand | -185.96 Thousand | -0.37 | - | 0.38 |
| Net cash flow / Change in cash | -5.2 Million | -123.39 Million | -135.45 Million | 747.38 Million | 57.36 Million | -34.42 Million |
| Free Cash Flow | -86.14 Million | 25.02 Million | -39.03 Million | 3.9 Million | 121.82 Million | 121.69 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.85 Million | 8.01 Million | 11.52 Million | -73.69 Million | -83.2 Million | -7.65 Million |
| Depreciation & Amortization | - | 23.28 Million | 23.28 Million | 84.46 Million | 84.46 Million | -41.86 Million |
| Deferred income taxes | - | - | - | - | -18.01 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -3.68 Million | - | -32.31 Million | -55.78 Million | 15.74 Million |
| Other non-cash items | 12.72 Million | 104.74 Million | 28.55 Million | 18.79 Million | 112.98 Million | 39.61 Million |
| Investing Cash Flow | -164.63 Million | -174.49 Million | -288.78 Million | -6.77 Million | -114.31 Million | -22.36 Million |
| Investments in PPE | -27.51 Million | -28.89 Million | -18.12 Million | -39.98 Million | -144.6 Million | -44.34 Million |
| Acquisitions | - | -148.6 Million | 4.6 Million | 11.64 Million | 21.96 Million | 16.93 Thousand |
| Investment purchases | 839 Million | -839 Million | - | -736.3 Million | -736.3 Million | 450.3 Million |
| Sales/Maturities of investments | 2.68 Million | 562 Million | 4.73 Million | 1.57 Million | 8.32 Million | 1.96 Million |
| Other Investing Activities | -139.8 Million | 280 Million | -275.39 Million | 31.64 Million | 21.96 Million | -430.29 Million |
| Financing Cash Flow | -38.03 Million | 1.97 Million | 36.69 Million | 6.55 Million | 53.17 Million | 67.26 Million |
| Debt repayment | -32.72 Million | -5.23 Million | -40.8 Million | -15.2 Million | -107.75 Million | -56.16 Million |
| Dividends payments | -3.6 Million | -2.87 Million | -2.44 Million | -34.43 Million | -34.43 Million | -3.34 Million |
| Common Stock Repurchased | - | - | - | -99.68 Thousand | -99.68 Thousand | 99.68 Thousand |
| Common Stock Issuance | - | - | - | - | - | -99.68 Thousand |
| Other Financing Activities | -1.7 Million | -1.21 Million | -1.65 Million | -1011.69 | -3.86 Million | 126.77 Million |
| Accounts receivables | - | 10.41 Million | - | -52.9 Million | -52.9 Million | 40.52 Million |
| Accounts payables | - | - | - | - | -9.57 Million | - |
| Inventory | - | -14.51 Million | - | 24.7 Million | 24.7 Million | -28.36 Million |
| Other working capital | - | 414.23 Thousand | - | -4.11 Million | -80.49 Million | 3.58 Million |
| Cash at beginning of period | 432.53 Million | 542.17 Million | 731.73 Million | 736.67 Million | 736.94 Million | 686.69 Million |
| Cash at end of period | 244.76 Million | 473.32 Million | 515.2 Million | 731.73 Million | 731.73 Million | 736.67 Million |
| Capital Expenditure | -27.51 Million | -28.89 Million | -18.12 Million | -39.98 Million | -144.6 Million | -44.34 Million |
| Effect of forex changes on cash | -101.91 Thousand | 373.43 Thousand | 216.38 Thousand | -1.95 Million | -2.52 Million | -440.65 Thousand |
| Net cash flow / Change in cash | -187.76 Million | -68.85 Million | -216.53 Million | -4.93 Million | -5.2 Million | 49.97 Million |
| Free Cash Flow | -9.94 Million | 60.58 Million | 17.22 Million | -42.75 Million | -86.14 Million | -38.51 Million |
COMFINCAP
009770
600839
RTC
TPTA
PAYT